MAP3K8 and Hepatic fibrosis: Collectively, our study identifies a novel and previously unappreciated role for TPL-2 as a molecular regulator of lipolysis in M2-MΦ’s, regulating type-2 inflammation, immunopathology and hepatic fibrosis.